Merck & Co., Inc.
MRK
Classifica tra le azioni
#41
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Prezzo delle azioni
$143.60
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$354.29B
Variazione (1 giorno)
-1.58%
Variazione (1 anno)
66.36%
Paese
US
Scambia Merck & Co., Inc. (MRK)
Categoria
Healthcare
Utile per Merck & Co., Inc. (MRK)
Utile nel Jun 2026 TTM: $5.95B
Secondo gli ultimi rapporti finanziari di Merck & Co., Inc., gli utili attuali della società sono $5.95B. Nel 2024, la società ha registrato un utile di $19.94B, un aumento rispetto a agli utili del 2023, che erano di $1.89B. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Merck & Co., Inc. dal 2000 al 2026
Utile alla fine di ogni anno
| Anno | Utile | Cambia |
|---|---|---|
| 2026 (TTM) | $5.95B | -71.77% |
| 2025 | $21.07B | 5.67% |
| 2024 | $19.94B | 955.37% |
| 2023 | $1.89B | -88.51% |
| 2022 | $16.44B | 18.48% |
| 2021 | $13.88B | 136.72% |
| 2020 | $5.86B | -18.24% |
| 2019 | $7.17B | -17.58% |
| 2018 | $8.70B | 33.43% |
| 2017 | $6.52B | 39.97% |
| 2016 | $4.66B | -13.74% |
| 2015 | $5.40B | -68.75% |
| 2014 | $17.28B | 211.69% |
| 2013 | $5.55B | -36.55% |
| 2012 | $8.74B | 19.16% |
| 2011 | $7.33B | 343.68% |
| 2010 | $1.65B | -89.19% |
| 2009 | $15.29B | 53.96% |
| 2008 | $9.93B | 194.63% |
| 2007 | $3.37B | -45.82% |
| 2006 | $6.22B | -15.51% |
| 2005 | $7.36B | -7.98% |
| 2004 | $8.00B | -11.59% |
| 2003 | $9.05B | -6.22% |
| 2002 | $9.65B | -2.98% |
| 2001 | $9.95B | 1.26% |
| 2000 | $9.82B | 0.00% |
Utile per aziende simili o concorrenti
| Azienda | Utile | Differenza negli utili | Il paese |
|---|---|---|---|
| $33.60B | 464.82% |
US
|
|
| $17.74B | 198.20% |
US
|
|
| $8.70B | 46.25% |
US
|
|
| $21.39B | 259.59% |
CH
|
|
| $16.38B | 175.36% |
CH
|
